EDIT — Editas Medicine Balance Sheet
0.000.00%
- $128.91m
- -$83.57m
- $32.31m
Annual balance sheet for Editas Medicine, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 402 | 500 | 344 | 323 | 270 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 6.05 | 0.267 | 5.14 | 10.2 | 16.3 |
Prepaid Expenses | |||||
Total Current Assets | 419 | 507 | 357 | 341 | 289 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 39.1 | 43.3 | 59.2 | 45.7 | 47.1 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 573 | 677 | 514 | 499 | 342 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 58.2 | 46.9 | 60.1 | 63.2 | 77.2 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 179 | 124 | 154 | 150 | 207 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 394 | 554 | 361 | 349 | 134 |
Total Liabilities & Shareholders' Equity | 573 | 677 | 514 | 499 | 342 |
Total Common Shares Outstanding |